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Abstract
Objectives: Morbidity after pancreaticoduodenectomy (PD) remains high. Computed tomography (CT)
of intra-abdominal tissue has not been thoroughly evaluated to establish associations with the occurrence
of complications after PD. The current study sought to determine whether differences in non-enhanced
visceral attenuation predicted complications after PD.
Methods: Outcomes in patients undergoing PD were analysed according to the Clavien system for
classifying complications and the International Study Group on Pancreatic Fistula system for classifying
postoperative pancreatic fistula (POPF). Preoperative non-enhanced CT scans were evaluated by a
blinded investigator for attenuation of abdominal viscera and fat thickness. Data on pancreatic firmness
and pancreatic duct size were collected. Univariate and multivariate analyses were performed.
Results: A total of 134 patients underwent PD for malignant and benign disease. Rates of morbidity,
mortality and POPF at 90 days were 61%, 4% and 23%, respectively. Patients with a body mass index
of > 25 kg/m2 had higher rates of POPF (P = 0.05) and complications (P < 0.01). In multivariate analysis,
patients were more likely to develop any complication as CT attenuation decreased for paraspinus muscle
(P < 0.01), spleen (P < 0.03) and liver (P = 0.01) parenchyma.
Conclusions: Postoperative complications after PD remain prevalent. Decreased CT attenuation of
abdominal viscera is an independent predictor of morbidity after PD and suggests a high-risk patient
physiology for pancreatic resection.
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Introduction
Morbidity and mortality rates following operations are often
determined at 30 days and seldom refer to the entire in-hospital
course. Furthermore, 90-day rates of morbidity and mortality
following pancreaticoduodenectomy (PD) at high-volume centres
have only recently been published, at 55% and 4.7%, respectively.1
Risk assessment is paramount to stratify patients who are at high
risk for poor outcomes. Several validated models, such as the
American Society of Anesthesiologists (ASA) class, POSSUM
(physiological and operative severity score for the enumeration of
mortality and morbidity), Charlson, SOAR (systolic blood pres-
sure, oxygenation, age and respiratory rate) and the American
College of Surgeons National Surgical Quality Improvement
Program (ACS-NSQIP) models, have emerged to aid in patient
selection and ameliorate poor surgical outcomes.2–7 Of these, only
NSQIP accounts for body mass index (BMI) and none account for
computed tomography (CT) attenuation values.
Up to 30% of patients presenting for PD are obese; over 35% of
these patients experience complications after PD and 24% expe-
rience a serious complication, compared with 14% of patients of
normal weight.8 Obesity is associated with increases in the inci-
dence of wound infections and postoperative pancreatic fistula
(POPF), estimated blood loss (EBL) and operative times.3,9
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Multiphasic CT is critical to operative planning for PD as it is
used to evaluate the resectability of tumours and the spatial rela-
tionship of structures adjacent to the pancreas. Although CT is
critical in the preoperative evaluation of patients scheduled to
undergo PD, no risk assessment tool utilizes CT to predict risk.
Computed tomography provides a measure of both abdominal
girth and visceral fat. House et al. showed that retrorenal fat of >
2 cm predicted adverse outcomes following PD.10 Computed tom-
ography also provides a measure of X-ray attenuation and thus
tissue density for specific regions of interest (RoI), measured in
Hounsfield units (HU). Hashimoto et al. described CT enhance-
ment of the pancreas to be a surrogate for pancreatic fibrosis,
which accurately predicted POPF.11
Historically, the main sources of morbidity and mortality fol-
lowing PD have been POPF and its sequelae, occurring at rates
as high as 30%.12 A critical review of the literature shows that
although the rate of POPF remains high, the majority of fistulae
are not significant; therefore most morbidity is caused by non-
fistulae sources. The metabolic syndrome of obesity is likely to
represent a significant contributor to morbidity following PD and
assessing for X-ray attenuation in HU may be used as a surrogate
for the adiposity of tissues. The present study therefore sought to
measure visceral attenuation in patients undergoing PD and to
compare these measurements with 90-day morbidity rates.
Materials and methods
Patients
Data for patients undergoing PD for both benign and malignant
disease, carried out at the University of Alabama at Birmingham
(UAB) by the senior author during 2005–2010 were collected into
a prospective database. The ACS-NSQIP and Charlson prediction
models were used to guide the collection of perioperative patient
characteristics.5 Medical records were retrospectively reviewed to
determine 90-day morbidity and mortality rates based on the
Clavien system of classification.13 Postoperative pancreatic fistula
and delayed gastric emptying (DGE) were classified as previously
described by the International Study Group on Pancreatic Fistula
(ISGPF) and the International Study Group of Pancreatic Surgery
(ISGPS), respectively.14,15
Operations included standard and pylorus-preserving PD.
Intraoperative assessment of pancreatic firmness (on a scale of
1–10) and duct diameter (in mm) were documented for each
patient. A 15-French round drain was left near the two-layer,
end-to-side, duct-to-mucosa pancreaticojejunostomy in all cases.
A free-floating silastic stent was used in all cases. Drain amylase
levels were routinely evaluated on postoperative day 4 or 5 to
determine POPF based upon ISGPF definitions.14
Computed tomography measurements
Radiographic consultation was used to assess each patient’s
preoperative imaging for quality. Preoperative imaging was
reviewed by one observer blinded to patient data and outcomes
(JCM). Only patients for whom preoperative non-enhanced CT
scans of the abdomen and pelvis were available were included in
the CT assessment of visceral attenuation and intra-abdominal
fat. Non-enhanced rather than contrasted studies were used to
assess parenchymal density in a manner that was not confounded
by vascular inflow/outflow and cardiac output characteristics.
Hip girdle, periumbilical and retrorenal fat thicknesses were
measured in millimetres as previously described.10 Attenuation
measurements (in HU) were placed for pancreatic, splenic,
hepatic and paraspinus muscle attenuation. For pancreatic attenu-
ation, the RoI was approximate to but did not include the superior
mesenteric artery and did not include the pancreatic duct. For
splenic, hepatic and paraspinus muscle attenuation, representative
RoIs were peripheral and distant from significant vasculature.
Statistics
Visceral organ attenuation, body fat thickness, POPF and Clavien
categories were compared according to demographics and clinical
characteristics by using analysis of variance (anova) and chi-
squared statistics for continuous and categorical variables, respec-
tively. Continuous variables were analysed using t-tests. Logistic
regression was used to determine associations with independent
variables. All analyses were performed using sas Version 9.2 (SAS
Institute, Inc., Cary, NC, USA).
Results
Patients and outcomes overview
The present group’s experience with PD at UAB included 332
patients during 2005–2010. Table 1 shows the characteristics of
the entire patient population presenting for PD during the period
under study. The mean age of these patients was 62 years and 55%
of patients were aged > 65 years. Patient gender was evenly dis-
tributed. Mean BMI was 27 kg/m2 and 24% of patients were obese
(BMI > 30 kg/m2). Over a third of patients were smokers at the
time of surgery. Most patients (53%) underwent PD for malignant
disease; the remainder underwent PD for chronic pancreatitis
(21%) or another benign aetiology (26%).
The mean total length of stay (LoS) during the initial 90 days
after surgery was 11 days including both preoperative and post-
operative days. The EBL during PD was 334 ml and 19% of
patients required red blood cell transfusions during this time-
frame. Overall 90-day morbidity and mortality rates were 66%
and 3%, respectively. Significant complications (Clavien class
 3) occurred in only 19% of patients. The overall rate of POPF
was 21%; however, the rate of clinically significant (grade B or C)
POPF was only 6%.
Preoperative CT subset analysis
Many of the patients referred to the present department presented
with CT imaging obtained at an outside facility. Radiologist con-
sultation was sought to evaluate imaging quality. This consulta-
tion sought to determine whether patients with appropriate
preoperative imaging were representative of the entire UAB series.
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Of the 332 patients, 134 patients had appropriate preoperative
non-enhanced CT that included all areas in which measurements
of fat thickness or visceral density were required. In the remaining
patients, preoperative imaging was not available or was of insuf-
ficient quality to allow adequate analysis. A subset analysis was
performed to compare the patient cohort with adequate preop-
erative imaging (n = 134) with that in which appropriate preop-
erative imaging was unavailable (n = 198). As Table 1 shows, all
variables except smoking status (P = 0.04) were equivalent (P >
0.05). This suggests that the 134 patients for whom preoperative
imaging was adequate were representative of the UAB experience.
Univariate analysis of complications following PD
Patient characteristics and resulting complications in the 134
patients with adequate preoperative imaging are shown in Table 2.
A total of 82 (61%) patients experienced a postoperative compli-
cation. The most common complications following PD in this
cohort were POPF (23%), intra-abdominal abscess (11%), respi-
ratory distress (11%) including pneumonia, DGE (10%) and
wound infection (10%). Patients who experienced complications
were more likely to be obese, have a BMI of > 25 kg/m2 (P < 0.01),
have a higher EBL (P < 0.05), and receive a red blood cell trans-
fusion during the operation or during their first hospital stay (P <
0.01). The occurrence of a postoperative complication increased
the mean LoS from 8.4 days to 13.3 days (P < 0.01).
Computed tomography measurements and
univariate analysis
Preoperative non-enhanced abdominal CT images were evaluated
for pancreatic, splenic, hepatic and paraspinus muscle attenua-
tion, as well as for fat thickness as depicted in Fig. 1. Mean values
were obtained in the group of patients who experienced any post-
operative complication and in those who did not. Table 3 shows
that mean pancreatic (P = 0.13), splenic (P = 0.03), hepatic (P <
0.01) and muscle (P < 0.01) attenuation were lower in patients
who experienced a complication. Increased periumbilical fat
Table 1 Patient cohort, complications overview and computed tomography subset analysis
Characteristics All patients (n = 332) Preoperative non-enhanced CT P-value
Yes (n = 134) No (n = 198)
Age, years, mean  SD 62.1  11.4 62.7  12.3 61.7  14.1 0.52
Elderly, % 55% 56% 54% 0.81
Male gender, % 49% 51% 47% 0.43
Body mass index, kg/m2, mean  SD 27.0  10.9 26.5  5.7 27.5  13.2 0.39
Obese, % 24% 24% 24% 0.86
Smokers, % 35% 28% 39% 0.04
Histology, % 0.48
Pancreatic adenocarcinoma 40% 41% 41%
Ampullary adenocarcinoma 6% 5% 8%
Cholangiocarcinoma 5% 5% 4%
Duodenal cancer 2% 1% 2%
Chronic pancreatitis 21% 23% 18%
Benign or cystic lesion 26% 25% 27%
Length of stay, days, mean  SD 11  8 11  9 11  7 0.52
Estimated blood loss, ml, mean  SD 334  245 337  291 332  210 0.88
Transfusion, % 19% 17% 20% 0.60
Complications, % 66% 61% 69% 0.16
Clavien class 1 12% 7% 15%
Clavien class 2 36% 37% 35%
Clavien class 3 8% 5% 10%
Clavien class 4 8% 8% 7%
Clavien class 5 3% 4% 2%
Postoperative pancreatic fistula, % 21% 23% 20% 0.48
ISGPF grade A 16% 19% 14%
ISGPF grade B 4% 2% 5%
ISGPF grade C 2% 2% 1%
CT, computed tomography; SD, standard deviation; ISGPF, International Study Group on Pancreatic Fistula.
All outcomes are evaluations within 90 days of pancreaticoduodenectomy.
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thickness (P < 0.01) and decreased pancreatic firmness (P < 0.01)
were both associated with an increased incidence of postoperative
complications in univariate analysis. Pancreatic firmness did not
correlate with pancreatic parenchymal CT attenuation (P = 0.18).
Hip girdle (P = 0.22) and retrorenal fat thickness (P = 0.06) were
not significantly associated with postoperative complications.
Pancreatic duct diameter was not associated with an elevated
complication rate following PD (P = 0.19).
Table 4 shows that a BMI of > 25 kg/m2 (P = 0.05), decreased
pancreatic firmness (P < 0.01) and decreased pancreatic duct
diameter (P < 0.01) were associated with an increased rate of
POPF in univariate analysis. Visceral attenuation and fat thickness
did not correlate with POPF (P < 0.05) in the present cohort.
Multivariate analysis
The regression model used in the present study controlled for age,
LoS, transfusion, periumbilical fat thickness and pancreatic firm-
ness. Decreased splenic [odds ratio (OR) 0.95, 95% confidence
interval (CI) 0.90–1.00], paraspinus muscle (OR 0.95, 95% CI
0.91–0.99) and hepatic (OR 0.95, 95% CI 0.91–0.99) attenuation
independently predicted postoperative complications following
PD. Pancreatic attenuation did not predict complications in this
regression model (OR 0.98, 95% CI 0.95–1.01). When the regres-
sion model controlled for BMI, visceral attenuation did not
predict postoperative complications.
Next, the study sought to determine whether visceral attenua-
tion was associated with specific complications following PD.
Findings showed that decreased attenuation of paraspinus muscle
predicted postoperative pneumonia (OR 0.87, 95% CI 0.79–0.98).
The mean  standard deviation (SD) attenuation of paraspinus
muscle was 24.8 8.1 in patients who experienced postoperative
pneumonia compared with 42.2 12.1 in those who did not (P =
0.005). The study also found that liver attenuation predicted
wound infection (OR 0.91, 95% CI 0.86–0.98) and intra-
abdominal infection or abscess (OR 1.1, 95% CI 1.0–1.2). The
mean  SD attenuation of the liver was 40.1  12.0 and 51.4 
11.2, respectively, in patients with and without a wound infection
(P = 0.004). The mean  SD attenuation of the liver was 62.1 
16.3 and 50.3  11.29, respectively, in patients with and without
an abdominal infection (P = 0.04).
Discussion
This study reports that in patients presenting with non-enhanced
preoperative CT, attenuation of viscera is an independent predic-
tor of complications following PD. The present study is one of the
few to assess CT attenuation and fat thickness. Interestingly, it
demonstrates that, in the present cohort of patients, decreased
attenuation of organs not involved in PD (spleen, liver, paraspinus
muscle) are predictive of complications. This finding may suggest
that overall decreased body density, or perhaps increased adipos-
ity, aids in the identification of those at high risk for complications
following PD.
The question of what the decreased attenuation of ‘normal’
viscera indicates remains. Computed tomography differs from
traditional radiography in that it displays various X-ray attenua-
tions through a section of the body tissue on a grey scale. X-ray
attenuation is measured in HU. Hounsfield units represent a
measure of tissue density on non-enhanced images or a combi-
nation of density and vascularity following i.v. contrast enhance-
ment with iodinated contrast material.16 By convention, an HU
value of 0 describes the attenuation coefficient of water, a value of
- 1000 describes that of air, and a value of + 1000 describes that of
bone. Thus the spectrum of HU can be used to evaluate the
character of tissues in terms of density. Tissue with an increased
HU value consists of more collagen, fibrosis and/or bone. By
contrast, tissue with a lower HU value consists of more air, fat
and/or water. In the present series, decreased attenuation is likely
to relate to an increase in adiposity and a decrease in fibrosis.
However, this is speculative because this study did not attempt to
Table 2 Univariate analysis of patient characteristics and complications in patients with preoperative non-enhanced computed tomography
Characteristics Complication (Clavien class 1–5) P-value
Yes (n = 82) No (n = 52)
Body mass index, kg/m2, mean  SD 28  26 24  23 < 0.01
Obese, % 31% 11% < 0.01
Length of stay, days, mean  SD 13.3  11.3 8.4  2.1 < 0.01
Transfusion, % 26% 2% < 0.01
Estimated blood loss, ml, mean  SD 377  329 268  196 < 0.05
Age, years, mean  SD 62  13 63  11 0.68
Elderly, % 54% 57% 0.77
Male gender, % 61% 55% 0.45
Smoker, % 25% 33% 0.30
Histology, % 62% 55% 0.44
SD, standard deviation.
All outcomes are evaluations within 90 days of pancreaticoduodenectomy.
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correlate pathologic specimens of spleen, hepatic or paraspinus
muscle tissue from PD patients; this represents a shortcoming of
the study. However, when multivariate analysis was controlled for
BMI, the attenuation of tissues did not predict complications.
This implies that the pathophysiology of adiposity played an
important role in the present cohort. Mechanistic validation by
pathologic review or serum reactive protein analysis is required.
Body mass index and obesity have been shown to impact on
overall survival and complication rates following both operations
and non-surgical medical care.17,18 The reasons for these impacts
are not entirely understood, but may relate to an imbalance of
proinflammatory and anti-inflammatory cytokines in obese sub-
jects.19 Obese patients have impaired natural killer cell, T cell and
neutrophil function, as well as an impaired response to stress as a
result of imbalances in tumour necrosis factor-a, interleukin-6
and macrophage function.20,21 Moreover, C-reactive protein,
amyloid A, fibrinogen and plasminogen activator inhibitor-1 are
elevated in obese patients.22–25 Overall, obese patients appear to
suffer from a chronic stress physiology that may contribute to the
occurrence of postoperative complications. The present group is
in the process of examining preoperative reactive proteins,
markers of nutrition and inflammation to better understand the
present CT findings and patient outcomes after PD. Likewise,
prospective studies with multiple radiologic reviewers will be
required to determine whether this group’s findings can be gen-
eralized and used to aid in preoperative risk stratification and
patient education in routine practice.
Figure 1 Examples of preoperative computed tomography (CT)
attenuation and fat thickness measurements. Axial non-enhanced
preoperative CT is evaluated for pancreaticoduodenectomy for
treatment of a duodenal carcinoma. (a) Regions of interest with
associated attenuation values in Hounsfield units (HU) of the pan-
creas, spleen, liver and paraspinus muscle. (b) Measurement of
periumbilical fat thickness in mm. (c) Measurement of hip girdle fat
thickness in mm. (d) Measurement of retrorenal fat thickness in mm
Table 3 Univariate analysis of computed tomography measure-
ments, intraoperative pancreatic character and 90-day
complications
Variable Complication (Clavien class 1–5) P-value
Yes No
Mean  SD Mean  SD
Attenuation
Paraspinus muscle 39.2  12.7 45.4  10.9 < 0.01a
Spleen 42.1  9.7 45.9  9.9 0.03a
Liver 48.8  12.7 53.4  9.1 0.01a
Pancreas 27.9  13.7 31.7  14.3 0.13
Fat thickness, mm
Periumbilical 27.6  18.1 20.9  10.7 < 0.01
Hip girdle 49.8  17.0 46.0  16.9 0.22
Retrorenal 10.9  8.8 8.1  8.2 0.06
Pancreatic character
Firmnessb 0.45  0.22 0.54  0.24 < 0.01
Duct diameter, mm 3.72  1.64 3.99  1.77 0.19
aRemained significant (P < 0.05) in multivariate analysis controlling for
age, length of stay, transfusion, periumbilical fat thickness and pancre-
atic firmness.
bFirmness = x/10 where x is a numerical value on a scale of 1–10, on
which 10 = a hard, very firm texture and 1 = a very soft texture.
SD, standard deviation.
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Previous work from the Mayo Clinic showed that pancreatic
enhancement on delayed i.v. contrasted CT related to pancreatic
fibrosis (attributable to the ‘wash in’ of the extracellular fluid
distribution of iodinated contrast media) and a decreased rate of
POPF.11 In this regard, pancreatic fibrosis appears to be better
evaluated in contrast-enhanced studies. The protocol for
enhanced CT varies among institutions. A fair number of the
present patients presented with preoperative imaging sourced
elsewhere. Thus, the present authors were unable to control the
protocol of these imaging studies. Moreover, enhanced studies are
limited by patient characteristics such as cardiac output. In addi-
tion, the ‘wash in’ and ‘wash out’ of contrast vary depending on the
pathology of tissue and according to local blood flow mechanics.
Therefore, the present study did not analyse findings in patients
with contrasted studies because this study would have been
underpowered to make any conclusions in contexts that included
so many potential variables.
Previous reports show that surgeon-evaluated pancreatic firm-
ness is predictive of postoperative complications, specifically
POPF.26 The present data corroborate these findings. The most
notorious complication following PD is POPF. Investigators
suggest that POPF is caused by deceased pancreatic firmness or
fibrosis or decreased duct size.27,28 Importantly, the present data
show that POPF, occurring in 21% of patients, was significant in
only a minority of them. Therefore, of all the complications, only
a small percentage of those that were clinically significant were
related to POPF. This may explain why pancreatic attenuation did
not independently predict complications following PD. Although
visceral attenuation did not predict POPF, attenuation did predict
other complications such as pneumonia and wound infection.
In conclusion, decreased CT attenuation of viscera is an inde-
pendent predictor of complications following PD. A combination
of preoperative patient factors and CT attenuation characteristics
may help to better identify patients at high risk for complications
following PD. That said, a prospective data collection combined
with tissue and serum validation is required to determine the
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